<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11864867</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.141</article-id><article-id pub-id-type="other">O0004</article-id><article-id pub-id-type="pii">S092493382400141X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>Early-onset obsessive-compulsive disorder: sociodemographic and clinical characterization of a large outpatient cohort</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Benatti</surname><given-names>B.</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0008" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor0002" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Girone</surname><given-names>N.</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vismara</surname><given-names>M.</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bucca</surname><given-names>C.</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dell&#x02019;Osso</surname><given-names>B.</given-names></name><xref rid="aff0007" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0008" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0009" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff0007">
<sup>1</sup>Department of Mental Health, <institution>Sacco University Hospital</institution></aff><aff id="aff0008">
<sup>2</sup>Center for Neurotechnology and Brain Therapeutic, Aldo Ravelli Center, <institution>University of Milan</institution>, <city>Milan</city>, <country>Italy</country></aff><aff id="aff0009">
<sup>3</sup>Department of Psychiatry and Behavioral Sciences, Bipolar Disorders Clinic, <institution>Stanford University</institution>, <city>Stanford</city>, <country>United States</country></aff><author-notes><corresp id="cor0002"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="116">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S42</fpage><lpage>S42</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400141Xa.pdf"/><abstract><sec id="sec0007"><title>Introduction</title><p>Obsessive-compulsive disorder (OCD) is a prevalent and disabling condition characterized by a wide variety of phenotypic expressions. Several studies have reinforced the hypothesis of OCD heterogeneity by proposing subtypes based on predominant symptomatology (Mataix-Cols et al., 2005), course (Tukel et al., 2007), and comorbidities (Mahasuar et al., 2011). Early-onset OCD could be considered a neurodevelopmental subtype of OCD, with evidence of distinct neurocircuits supporting disease progression (Park et al., 2022).</p></sec><sec id="sec0008"><title>Objectives</title><p>The aim of the present study is to evaluate the sociodemographic and clinical differences between the early-onset and late-onset subtypes in a large patient cohort.</p></sec><sec id="sec0009"><title>Methods</title><p>Two hundred and eighty patients diagnosed with OCD were consecutively recruited from the OCD Tertiary Clinic at Luigi Sacco University Hospital in Milan. Sociodemographic and clinical variables were analyzed for the entire sample and compared between the two subgroups (EO: early-onset, age &#x0003c;18 years [40%]; LO: late-onset, age &#x02265; 18 years [60%]).</p></sec><sec id="sec0010"><title>Results</title><p>The EO group showed a higher frequency of male gender (65.5% vs 34.5%, p&#x0003c; .001, see Figure 1a), a higher presence of lifetime psychiatric comorbidities (75.7% vs 24.3%, p =.025), and higher rates of Tic and Tourette disorders (7.2% vs 0%, p=.006) compared to the LO group. Additionally, in the EO subgroup, a longer duration of untreated illness was observed (9.05 &#x000b1; 10.0 vs 5 &#x000b1; 7.17; p&#x0003c;.001, see Figure 1b), along with a lower presence of insight (33.3% vs. 66.7%, p =.024). No significant differences emerged in the Yale-Brown Obsessive-Compulsive Scale scores between the groups.</p><p>
<bold>Image:</bold>
</p><p>
<fig position="float" id="fig0182"><graphic xlink:href="S092493382400141X-FIG0182" position="anchor"/></fig>
</p><p>
<bold>Image 2:</bold>
</p><p>
<fig position="float" id="fig0183"><graphic xlink:href="S092493382400141X-FIG0183" position="anchor"/></fig>
</p></sec><sec id="sec0011"><title>Conclusions</title><p>The early-onset OCD subtype highlights a more severe psychopathological profile compared to the late-onset group. Exploring distinct manifestations and developmental trajectories of OCD can contribute to a better definition of homogeneous subtypes, useful for studying risk factors and defining targeted therapeutic strategies for treatment.</p></sec><sec id="sec0012"><title>Disclosure of Interest</title><p>B. Benatti Speakers bureau of: Angelini, Lundbeck, Janssen, Rovi, N. Girone: None Declared, M. Vismara: None Declared, C. Bucca: None Declared, B. Dell&#x02019;Osso Grant / Research support from: Angelini, Lundbeck, Janssen, Pfizer, Otzuka, Neuraxpharm, and Livanova, Speakers bureau of: Angelini, Lundbeck, Janssen, Pfizer, Otzuka, Neuraxpharm, and Livanova.</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>